| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | IQSEC3 MYCBP2 MCF2L2 ARHGEF38 RAPGEF1 DENND2B ARFGEF3 RAB3IP DNMBP SH3BP5 | 1.69e-06 | 231 | 123 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 IQSEC3 TANK MYCBP2 GAS6 MCF2L2 ARHGEF38 RAPGEF1 DENND2B RGS12 ARFGEF3 THBS1 SERPINB9 RAB3IP MAP3K13 BSN POLG2 DNMBP SH3BP5 SORL1 SPINK5 WDTC1 | 5.04e-05 | 1418 | 123 | 22 | GO:0030234 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 IQSEC3 MYCBP2 MCF2L2 ARHGEF38 RAPGEF1 DENND2B RGS12 ARFGEF3 RAB3IP DNMBP SH3BP5 | 7.06e-05 | 507 | 123 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 IQSEC3 MYCBP2 MCF2L2 ARHGEF38 RAPGEF1 DENND2B RGS12 ARFGEF3 RAB3IP DNMBP SH3BP5 | 7.06e-05 | 507 | 123 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.74e-04 | 18 | 123 | 3 | GO:0030169 | |
| Domain | INT_SG_DDX_CT_C | 1.45e-05 | 8 | 121 | 3 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 1.45e-05 | 8 | 121 | 3 | IPR029307 | |
| Domain | TSP_1 | 5.47e-05 | 63 | 121 | 5 | PF00090 | |
| Domain | TSP1 | 6.36e-05 | 65 | 121 | 5 | SM00209 | |
| Domain | TSP1_rpt | 6.36e-05 | 65 | 121 | 5 | IPR000884 | |
| Domain | TSP1 | 6.36e-05 | 65 | 121 | 5 | PS50092 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.12e-05 | 68 | 87 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.44e-05 | 39 | 87 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.44e-05 | 39 | 87 | 4 | MM15165 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 TET2 HIVEP1 TTC28 MYCBP2 TEX2 MATR3 BACH1 DENND2B RGS12 STIM1 ARFGEF3 MTMR4 PTPN13 ALMS1 PHF3 PLCH1 DNMBP WDR62 | 4.33e-10 | 861 | 128 | 19 | 36931259 |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | 1.82e-09 | 15 | 128 | 5 | 15905330 | |
| Pubmed | RIOK1 WAPL TANK TTC28 MYCBP2 TEX2 VPS4B SRPRA ICE1 PAPOLG JPH1 MTMR4 ALMS1 CEBPZ PHF3 PLCH1 WDR62 | 1.86e-09 | 733 | 128 | 17 | 34672954 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | FAM193B MATR3 RNF115 AKAP8L PTPN13 LPIN2 PLCH1 DYNC1H1 WDR62 WDTC1 | 1.64e-08 | 232 | 128 | 10 | 25515538 |
| Pubmed | CEP104 USP53 TET2 WAPL RRP1B TEX2 MATR3 ICE1 FEM1C KIAA1614 SENP6 BSN DNMBP | 8.69e-08 | 529 | 128 | 13 | 14621295 | |
| Pubmed | 2.60e-07 | 71 | 128 | 6 | 33541421 | ||
| Pubmed | RGPD4 TET2 HIVEP1 TTC28 MYCBP2 VPS4B ICE1 AKAP8L PTPN13 ALMS1 WDR62 | 4.58e-07 | 418 | 128 | 11 | 34709266 | |
| Pubmed | EAPP RRP1B MYCBP2 TEX2 UNC5B BACH1 OBSL1 SRPRA CCDC77 DNTTIP2 JPH1 STIM1 PTPN13 CEBPZ HTATSF1 PLCH1 SUCO EIF2AK3 PBXIP1 WDR62 | 5.36e-07 | 1487 | 128 | 20 | 33957083 | |
| Pubmed | 5.63e-07 | 130 | 128 | 7 | 12421765 | ||
| Pubmed | TET2 WAPL TTC28 MYCBP2 BACH1 MCF2L2 OBSL1 CMYA5 AKAP8L JPH1 THBS1 PTPN13 FBN1 ADAMTS9 SENP6 PBXIP1 DYNC1H1 SH3BP5 | 1.19e-06 | 1285 | 128 | 18 | 35914814 | |
| Pubmed | IQSEC3 TTC28 OBSL1 ADGRL1 CSMD3 ARFGEF3 KANSL1 PHF3 DYNC1H1 PDZD2 | 2.87e-06 | 407 | 128 | 10 | 12693553 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | WAPL RRP1B MYCBP2 AKAP8L DNTTIP2 CEBPZ PHF3 NKTR UTP3 EIF2AK3 | 5.70e-06 | 440 | 128 | 10 | 34244565 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | WAPL HIVEP1 MYCBP2 MATR3 BACH1 REXO1 AKAP8L PAPOLG KANSL1 PHF3 SENP6 DNMBP WDR62 | 6.01e-06 | 774 | 128 | 13 | 15302935 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 8.16e-06 | 361 | 128 | 9 | 26167880 | |
| Pubmed | 1.31e-05 | 209 | 128 | 7 | 36779422 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 30720688 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23994313 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 9188474 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 36383638 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33802838 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12101265 | ||
| Pubmed | 4.58e-05 | 347 | 128 | 8 | 17114649 | ||
| Pubmed | 5.30e-05 | 20 | 128 | 3 | 36551904 | ||
| Pubmed | RIOK1 TTC28 UNC5B SRPRA THSD1 JPH1 STIM1 PTPN13 PLCH1 EIF2AK3 DYNC1H1 | 6.50e-05 | 708 | 128 | 11 | 39231216 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 TTC28 OBSL1 PAPOLG ARFGEF3 ALMS1 SENP6 BSN DNMBP SORL1 | 6.73e-05 | 588 | 128 | 10 | 38580884 |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 15371459 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 8.48e-05 | 120 | 128 | 5 | 31413325 | |
| Pubmed | 9.23e-05 | 493 | 128 | 9 | 15368895 | ||
| Pubmed | 9.36e-05 | 285 | 128 | 7 | 32838362 | ||
| Pubmed | 9.37e-05 | 64 | 128 | 4 | 20332099 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.81e-05 | 497 | 128 | 9 | 36774506 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RIOK1 RRP1B MYCBP2 BACH1 OBSL1 RSPRY1 STIM1 PTPN13 NPHP3 RAB3IP NKTR DYNC1H1 WDR62 SORL1 WDTC1 | 1.09e-04 | 1321 | 128 | 15 | 27173435 |
| Pubmed | 1.25e-04 | 513 | 128 | 9 | 25798074 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTC28 RRP1B MYCBP2 TEX2 MATR3 OBSL1 SRPRA CCDC77 JPH1 STIM1 ARFGEF3 ALMS1 UTP3 SUCO EIF2AK3 WDR62 | 1.26e-04 | 1496 | 128 | 16 | 32877691 |
| Pubmed | 1.33e-04 | 210 | 128 | 6 | 16565220 | ||
| Pubmed | NK lytic-associated molecule, involved in NK cytotoxic function, is an E3 ligase. | 1.33e-04 | 5 | 128 | 2 | 16709802 | |
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 29108636 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 15580571 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 23000413 | ||
| Pubmed | Mohawk is a novel homeobox gene expressed in the developing mouse embryo. | 1.33e-04 | 5 | 128 | 2 | 16408284 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CT45A1 TANK RRP1B AFF3 GAS6 INTS1 OBSL1 DNTTIP2 STIM1 CT45A3 NKTR MAP3K13 | 1.42e-04 | 910 | 128 | 12 | 36736316 |
| Pubmed | RIOK1 WAPL TTC28 OBSL1 SRPRA AKAP8L RSPRY1 PLCH1 PBXIP1 SORL1 | 1.53e-04 | 650 | 128 | 10 | 38777146 | |
| Pubmed | 1.93e-04 | 225 | 128 | 6 | 12168954 | ||
| Pubmed | The tight-skin (Tsk) mutation is closely linked to B2m on mouse chromosome 2. | 2.00e-04 | 6 | 128 | 2 | 8111131 | |
| Pubmed | 2.00e-04 | 6 | 128 | 2 | 34084167 | ||
| Pubmed | TET2 CT45A6 CT45A1 TRPA1 ZNF235 MEIS2 CT45A7 SERPINB9 FBN1 CT45A3 | 2.04e-04 | 674 | 128 | 10 | 37196079 | |
| Pubmed | 2.06e-04 | 549 | 128 | 9 | 38280479 | ||
| Pubmed | 2.13e-04 | 146 | 128 | 5 | 21399614 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.22e-04 | 231 | 128 | 6 | 16452087 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.27e-04 | 148 | 128 | 5 | 32538781 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B MYCBP2 INTS1 RAPGEF1 ADGRL1 ICE1 CNTROB REXO1 KANSL1 DOK4 UCKL1 DNMBP DYNC1H1 | 2.28e-04 | 1105 | 128 | 13 | 35748872 |
| Pubmed | 2.57e-04 | 446 | 128 | 8 | 24255178 | ||
| Pubmed | MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation. | 2.79e-04 | 7 | 128 | 2 | 24488098 | |
| Pubmed | Thbs1 induces lethal cardiac atrophy through PERK-ATF4 regulated autophagy. | 2.79e-04 | 7 | 128 | 2 | 34168130 | |
| Pubmed | 2.79e-04 | 7 | 128 | 2 | 36700049 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 WAPL EAPP MATR3 BACH1 AKAP8L JPH1 THBS1 KANSL1 HTATSF1 DYNC1H1 WDR62 WDTC1 | 3.48e-04 | 1155 | 128 | 13 | 20360068 |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 3.54e-04 | 468 | 128 | 8 | 31056421 | |
| Pubmed | 3.59e-04 | 469 | 128 | 8 | 27634302 | ||
| Pubmed | 3.71e-04 | 8 | 128 | 2 | 26718008 | ||
| Pubmed | Retinal transcriptome of neonatal mice after optic nerve injury. | 3.71e-04 | 8 | 128 | 2 | 37252932 | |
| Pubmed | 4.44e-04 | 263 | 128 | 6 | 34702444 | ||
| Pubmed | 4.69e-04 | 41 | 128 | 3 | 19343720 | ||
| Pubmed | 4.76e-04 | 9 | 128 | 2 | 30758286 | ||
| Pubmed | 5.27e-04 | 497 | 128 | 8 | 23414517 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 5.42e-04 | 101 | 128 | 4 | 24613305 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 5.50e-04 | 908 | 128 | 11 | 19274049 | |
| Pubmed | 5.63e-04 | 102 | 128 | 4 | 10231032 | ||
| Pubmed | 5.93e-04 | 10 | 128 | 2 | 10381505 | ||
| Pubmed | Identification of a new family of Pbx-related homeobox genes. | 5.93e-04 | 10 | 128 | 2 | 8950991 | |
| Pubmed | 5.93e-04 | 10 | 128 | 2 | 20488784 | ||
| Pubmed | 6.06e-04 | 104 | 128 | 4 | 10470851 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.51e-04 | 283 | 128 | 6 | 30585729 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FAM193B RIOK1 WAPL MATR3 ICE1 DNTTIP2 PTPN13 ALMS1 SENP6 HTATSF1 WDR62 | 6.94e-04 | 934 | 128 | 11 | 33916271 |
| Pubmed | Placental labyrinth formation in mice requires endothelial FLRT2/UNC5B signaling. | 7.23e-04 | 11 | 128 | 2 | 28576770 | |
| Pubmed | Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. | 7.23e-04 | 11 | 128 | 2 | 22488850 | |
| Pubmed | A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. | 7.23e-04 | 11 | 128 | 2 | 17903305 | |
| Pubmed | Thbs1 regulates skeletal muscle mass in a TGFβ-Smad2/3-ATF4-dependent manner. | 7.23e-04 | 11 | 128 | 2 | 38678560 | |
| Pubmed | 7.27e-04 | 191 | 128 | 5 | 31177093 | ||
| Pubmed | 7.46e-04 | 48 | 128 | 3 | 16421571 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WAPL HIVEP1 RRP1B MATR3 ICE1 DNTTIP2 CEBPZ PHF3 SENP6 HTATSF1 UTP3 | 8.25e-04 | 954 | 128 | 11 | 36373674 |
| Pubmed | USP11 deubiquitinates RAE1 and plays a key role in bipolar spindle formation. | 8.66e-04 | 12 | 128 | 2 | 29293652 | |
| Pubmed | WAPL TTC28 GAS6 OBSL1 AKAP8L DNTTIP2 JPH1 ALMS1 UCKL1 WDR62 SORL1 WDTC1 | 8.78e-04 | 1116 | 128 | 12 | 31753913 | |
| Pubmed | 9.76e-04 | 421 | 128 | 7 | 36976175 | ||
| Pubmed | 1.02e-03 | 13 | 128 | 2 | 11682476 | ||
| Pubmed | 1.02e-03 | 13 | 128 | 2 | 26989192 | ||
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 1.02e-03 | 13 | 128 | 2 | 20498044 | |
| Pubmed | RGPD4 IQSEC3 MYCBP2 TEX2 BACH1 ADGRL1 SRPRA AKAP8L STIM1 ARFGEF3 PRICKLE2 BSN | 1.05e-03 | 1139 | 128 | 12 | 36417873 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.06e-03 | 208 | 128 | 5 | 33230847 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | WAPL RRP1B MATR3 SRPRA AKAP8L DNTTIP2 PAPOLG CT45A3 CEBPZ PHF3 UTP3 | 1.10e-03 | 989 | 128 | 11 | 36424410 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.12e-03 | 695 | 128 | 9 | 23602568 | |
| Pubmed | 1.17e-03 | 56 | 128 | 3 | 27103069 | ||
| Pubmed | 1.19e-03 | 14 | 128 | 2 | 36108118 | ||
| Pubmed | WAPL RRP1B MATR3 AKAP8L DNTTIP2 CEBPZ PHF3 UTP3 CDCA7L WDR62 | 1.19e-03 | 847 | 128 | 10 | 35850772 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 RIOK1 TANK TTC28 CCDC77 RGS12 ALMS1 DNMBP DYNC1H1 WDR62 | 1.26e-03 | 853 | 128 | 10 | 28718761 |
| Pubmed | 1.37e-03 | 15 | 128 | 2 | 36207400 | ||
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 1.39e-03 | 130 | 128 | 4 | 26598620 | |
| Pubmed | 1.42e-03 | 222 | 128 | 5 | 35941108 | ||
| Pubmed | 1.42e-03 | 222 | 128 | 5 | 37071664 | ||
| Pubmed | 1.56e-03 | 16 | 128 | 2 | 7633422 | ||
| Pubmed | 1.56e-03 | 16 | 128 | 2 | 31669249 | ||
| Interaction | SFN interactions | USP53 TET2 MYCBP2 TEX2 MATR3 BACH1 COP1 DENND2B RNF115 RGS12 MTMR4 PTPN13 ALMS1 PHF3 RAB3IP PLCH1 DNMBP WDR62 | 3.09e-07 | 692 | 126 | 18 | int:SFN |
| Interaction | YWHAH interactions | USP53 TET2 HIVEP1 TTC28 MYCBP2 TEX2 MATR3 DENND2B RNF115 RGS12 STIM1 ARFGEF3 IFIH1 MTMR4 PTPN13 ALMS1 PHF3 MTBP NKTR PLCH1 DNMBP SUCO WDR62 | 3.10e-07 | 1102 | 126 | 23 | int:YWHAH |
| Interaction | YWHAB interactions | TET2 DDIT4 RIOK1 HIVEP1 TTC28 MYCBP2 MATR3 COP1 DENND2B RNF115 RGS12 STIM1 MTMR4 PTPN13 PHF3 MTBP PLCH1 DNMBP SUCO DYNC1H1 WDR62 | 1.24e-06 | 1014 | 126 | 21 | int:YWHAB |
| Interaction | YWHAZ interactions | TET2 DDIT4 HIVEP1 TTC28 MYCBP2 TEX2 MATR3 OBSL1 COP1 SRPRA DENND2B RNF115 RGS12 STIM1 MTMR4 PTPN13 PHF3 LPIN2 MTBP PLCH1 DNMBP SUCO DYNC1H1 WDR62 | 1.92e-06 | 1319 | 126 | 24 | int:YWHAZ |
| Interaction | YWHAG interactions | USP53 TET2 HIVEP1 TTC28 MYCBP2 MATR3 DENND2B RNF115 RGS12 DNTTIP2 STIM1 MTMR4 PTPN13 ALMS1 PHF3 MTBP NKTR PLCH1 DNMBP SUCO DYNC1H1 WDR62 | 9.11e-06 | 1248 | 126 | 22 | int:YWHAG |
| Interaction | FBXW11 interactions | FAM193B HIVEP1 MATR3 RAPGEF1 RNF115 AKAP8L PTPN13 LPIN2 PLCH1 DYNC1H1 WDR62 WDTC1 | 4.21e-05 | 473 | 126 | 12 | int:FBXW11 |
| Cytoband | Xq26.3 | 1.31e-06 | 67 | 128 | 5 | Xq26.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | 9.11e-06 | 171 | 128 | 6 | chrXq26 | |
| Cytoband | 2q24 | 4.17e-04 | 11 | 128 | 2 | 2q24 | |
| GeneFamily | Classical BAR domain containing | 4.80e-04 | 8 | 76 | 2 | 1292 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP | 3.93e-06 | 86 | 127 | 6 | M19610 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | 2.16e-05 | 69 | 127 | 5 | M45681 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DDIT4 WAPL TANK MYCBP2 MATR3 RAPGEF1 SRPRA ICE1 USP20 DNTTIP2 PAPOLG STIM1 SERPINB9 KANSL1 PHF3 LPIN2 SENP6 PBXIP1 DYNC1H1 SORL1 | 3.29e-05 | 1492 | 127 | 20 | M40023 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 4.61e-05 | 194 | 127 | 7 | M7306 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP | 5.59e-05 | 200 | 127 | 7 | M9314 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 5.59e-05 | 200 | 127 | 7 | M9348 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 5.59e-05 | 200 | 127 | 7 | M3675 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | TTC28 AFF3 ARHGEF38 DENND2B ARFGEF3 MFSD2A PTPN13 MAP3K13 PLCH1 SPINK5 | 1.75e-10 | 188 | 127 | 10 | ec38def1fdbb34ed9b30244806975bd5a4370164 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | AFF3 ARHGEF38 DENND2B ARFGEF3 MFSD2A PTPN13 MAP3K13 PLCH1 PDZD2 | 4.47e-09 | 192 | 127 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.20e-08 | 185 | 127 | 8 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-08 | 191 | 127 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-08 | 191 | 127 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 8.26e-08 | 192 | 127 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 8.59e-08 | 193 | 127 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.94e-08 | 194 | 127 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.72e-07 | 183 | 127 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.01e-06 | 184 | 127 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-06 | 186 | 127 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-06 | 187 | 127 | 7 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.29e-06 | 191 | 127 | 7 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.29e-06 | 191 | 127 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 192 | 127 | 7 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 127 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 127 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.44e-06 | 194 | 127 | 7 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 196 | 127 | 7 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 196 | 127 | 7 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-06 | 196 | 127 | 7 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 198 | 127 | 7 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-06 | 198 | 127 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-06 | 199 | 127 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-06 | 199 | 127 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.70e-06 | 199 | 127 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.70e-06 | 199 | 127 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.76e-06 | 200 | 127 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.76e-06 | 200 | 127 | 7 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 7.96e-06 | 165 | 127 | 6 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|Classical_Monocyte / Disease condition and Cell class | 1.11e-05 | 175 | 127 | 6 | 35ea2ed93538e6bf803029fcf7d9243f93e7733d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-05 | 178 | 127 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 179 | 127 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 179 | 127 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.31e-05 | 180 | 127 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_1|COVID-19_Severe / Disease condition and Cell class | 1.35e-05 | 181 | 127 | 6 | 0d07a67e8ee3bca687b378afbc4044434e63556d | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.43e-05 | 183 | 127 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 183 | 127 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.53e-05 | 185 | 127 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.53e-05 | 185 | 127 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.67e-05 | 188 | 127 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.67e-05 | 188 | 127 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.72e-05 | 189 | 127 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-05 | 189 | 127 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 190 | 127 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.77e-05 | 190 | 127 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 191 | 127 | 6 | 471205494b91be69926dc8159376132bcea0d9b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 191 | 127 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-05 | 191 | 127 | 6 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-05 | 191 | 127 | 6 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.83e-05 | 191 | 127 | 6 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.83e-05 | 191 | 127 | 6 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.83e-05 | 191 | 127 | 6 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.83e-05 | 191 | 127 | 6 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.88e-05 | 192 | 127 | 6 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 192 | 127 | 6 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 1.88e-05 | 192 | 127 | 6 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.88e-05 | 192 | 127 | 6 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 192 | 127 | 6 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.88e-05 | 192 | 127 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 193 | 127 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | COVID-19-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 1.94e-05 | 193 | 127 | 6 | 6e6a7f4e50c8ae70bc187b9ce77140a7049dd288 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 193 | 127 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 194 | 127 | 6 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.99e-05 | 194 | 127 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-05 | 195 | 127 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 195 | 127 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.05e-05 | 195 | 127 | 6 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-05 | 196 | 127 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 2.11e-05 | 196 | 127 | 6 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.24e-05 | 198 | 127 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-05 | 198 | 127 | 6 | 3a1707318814dabdec48f91fa6bd223f5b879653 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 127 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 199 | 127 | 6 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 127 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-05 | 199 | 127 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.37e-05 | 200 | 127 | 6 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.92e-05 | 139 | 127 | 5 | 7e2c10830c3d16109cab3ed0d64b3532481e497d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 142 | 127 | 5 | c2a3cd9998fd9a8e6b2665347ca5c32511776488 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.63e-05 | 143 | 127 | 5 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-05 | 148 | 127 | 5 | 1d9fa6b2ee9feaed39c63d44e638b5c0942d947c | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 7.52e-05 | 152 | 127 | 5 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.25e-05 | 155 | 127 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 164 | 127 | 5 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 164 | 127 | 5 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-04 | 164 | 127 | 5 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 166 | 127 | 5 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 166 | 127 | 5 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.17e-04 | 167 | 127 | 5 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 168 | 127 | 5 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 168 | 127 | 5 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 169 | 127 | 5 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 169 | 127 | 5 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 169 | 127 | 5 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-04 | 169 | 127 | 5 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | droplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-04 | 169 | 127 | 5 | 822e5b6c1e55e196e6d2a38bf183fd220c45703e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-04 | 170 | 127 | 5 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.40e-06 | 196 | 125 | 9 | 6062_UP | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 1.46e-06 | 197 | 125 | 9 | 5415_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.21e-05 | 194 | 125 | 8 | 2223_UP | |
| Drug | 5707885; Up 200; 50uM; PC3; HT_HG-U133A | 1.25e-05 | 195 | 125 | 8 | 6390_UP | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 1.35e-05 | 197 | 125 | 8 | 4532_DN | |
| Disease | apolipoprotein A 1 measurement | TET2 TCF15 THSD7A AFF3 LCAT RNF115 RSPRY1 DOK4 LPIN2 SP6 ABCB11 SORL1 | 1.55e-04 | 848 | 118 | 12 | EFO_0004614 |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.90e-04 | 28 | 118 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | lymphocyte count | TET2 NWD1 HIVEP1 TTC28 GAS6 MSR1 IFIH1 MFSD2A SERPINB9 FBN1 ALMS1 DCLRE1C SP6 PLEK ADGRE1 RNF39 | 2.43e-04 | 1464 | 118 | 16 | EFO_0004587 |
| Disease | Severe Congenital Microcephaly | 2.58e-04 | 31 | 118 | 3 | C3853041 | |
| Disease | Disproportionate short stature | 2.63e-04 | 77 | 118 | 4 | C0878659 | |
| Disease | Microlissencephaly | 3.12e-04 | 33 | 118 | 3 | C1956147 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 4.37e-04 | 8 | 118 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Subarachnoid Hemorrhage | 5.60e-04 | 9 | 118 | 2 | C0038525 | |
| Disease | colorectal cancer, endometrial neoplasm | 6.39e-04 | 42 | 118 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | age at menarche | 6.54e-04 | 594 | 118 | 9 | EFO_0004703 | |
| Disease | macula measurement | 9.97e-04 | 189 | 118 | 5 | EFO_0008375 | |
| Disease | intelligence, self reported educational attainment | 1.27e-03 | 117 | 118 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | Malformations of Cortical Development | 1.40e-03 | 14 | 118 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.40e-03 | 14 | 118 | 2 | C0431380 | |
| Disease | household income | 1.43e-03 | 304 | 118 | 6 | EFO_0009695 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.51e-03 | 670 | 118 | 9 | EFO_0006335, EFO_0006336 | |
| Disease | platelet crit | TET2 TTC28 AFF3 ITGAD DENND2B KIAA1614 THBS1 SERPINB9 KANSL1 PLEK SORL1 | 1.54e-03 | 952 | 118 | 11 | EFO_0007985 |
| Disease | Autosomal recessive primary microcephaly | 1.61e-03 | 15 | 118 | 2 | cv:C3711387 | |
| Disease | obesity (implicated_via_orthology) | 1.76e-03 | 215 | 118 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | choline measurement | 1.87e-03 | 130 | 118 | 4 | EFO_0010116 | |
| Disease | Muscle hypotonia | 2.07e-03 | 17 | 118 | 2 | C0026827 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.07e-03 | 17 | 118 | 2 | cv:C0270914 | |
| Disease | Intellectual Disability | 2.18e-03 | 447 | 118 | 7 | C3714756 | |
| Disease | Profound Mental Retardation | 2.39e-03 | 139 | 118 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.39e-03 | 139 | 118 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.39e-03 | 139 | 118 | 4 | C0917816 | |
| Disease | Microcephaly | 2.48e-03 | 67 | 118 | 3 | C0025958 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 2.59e-03 | 19 | 118 | 2 | EFO_0007709 | |
| Disease | fasting blood insulin measurement | 2.70e-03 | 69 | 118 | 3 | EFO_0004466 | |
| Disease | seborrheic dermatitis | 2.87e-03 | 20 | 118 | 2 | EFO_1000764 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.10e-03 | 355 | 118 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | Alzheimer disease, educational attainment | 3.21e-03 | 247 | 118 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | worry measurement | 3.45e-03 | 154 | 118 | 4 | EFO_0009589 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.48e-03 | 22 | 118 | 2 | C3711387 | |
| Disease | Renal glomerular disease | 3.80e-03 | 23 | 118 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.80e-03 | 23 | 118 | 2 | C4521256 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EESRSGETNSCVEEI | 291 | P51826 | |
| DDSRTASQLDEFQEC | 381 | Q8NHY2 | |
| TDTEGDSESCSAREQ | 506 | O14867 | |
| DFSLGSTVQFSCDED | 501 | Q7Z407 | |
| RTSSSIVFEDSGCDN | 801 | Q9NZJ5 | |
| AFEDDSCSNFVSEDD | 301 | O60239 | |
| SDLDESESCTAEDGA | 1356 | O94910 | |
| DCNSYLQRSTGEESD | 446 | Q9NXL2 | |
| EESECHSEFENTTRS | 3461 | Q8TCU4 | |
| VGECEQSESSAFKAD | 181 | Q9BR77 | |
| SFSGDDLECRETASS | 101 | P0DMU8 | |
| RECLTGESESSSEDE | 46 | Q56P03 | |
| DCNSVGELNTRFSDD | 191 | O95342 | |
| RTVDESVSSGNQDDC | 206 | Q6XZF7 | |
| SDSDSDDECNTLNGL | 1011 | P78524 | |
| SFSGDDLECRETASS | 101 | P0DMV0 | |
| ATTDSDERDDASVCS | 656 | O94823 | |
| DERDDASVCSGGDST | 661 | O94823 | |
| ATRTDCSDNSDSDND | 291 | Q9ULX6 | |
| GEEQDSLDTSSEIRC | 1246 | Q149M9 | |
| TEACDGSDDIFGLST | 141 | Q96QF0 | |
| TEGDTATFECELSQA | 1641 | O75147 | |
| ECGADVNVRDSDDNS | 516 | Q96JP0 | |
| DGERCRDDSFFGETS | 226 | P43243 | |
| AEAETRSQDGDTAAC | 1741 | Q8N201 | |
| REAIFDTLCTDDSSE | 136 | Q8N307 | |
| GSESGKDTCDEFRSQ | 766 | Q9NQ38 | |
| GDVCSSDSFNEDIAV | 111 | O14770 | |
| NESRNDDDDTSVCLG | 166 | Q9H9K5 | |
| SDANSTISFGDVDCD | 251 | Q9HDC5 | |
| DNSDNCRTDSEEAGT | 616 | Q5VZ46 | |
| RSADCSVQTDDEDSA | 2606 | Q9UPA5 | |
| GCSSREFSSMDTFED | 1006 | Q86YR7 | |
| RLSVSSDDSCSEDGE | 156 | Q8IYA7 | |
| TDFQSSDCLAREEVG | 316 | O15018 | |
| SFSGDDLECRETASS | 101 | Q8NHU0 | |
| LRCSEQAFDSDVTDS | 391 | Q7Z3B3 | |
| AEDCGVSDSELSFRE | 246 | Q969G2 | |
| SNFSSSDCQDEEGRK | 271 | Q9UHN1 | |
| CITFSTERVEGDDSQ | 566 | Q3SXY7 | |
| EESCDSFDSLESGKQ | 41 | Q96GN5 | |
| EDASAEDSCAEAAAS | 546 | Q9UPP2 | |
| TEDFGSDHSEDCLSE | 1081 | Q9NYA4 | |
| QEDTDSCSESVKFDA | 11 | P21757 | |
| DCSEKQSEDGSEREF | 551 | O43719 | |
| SDCAQDKSVFGETEE | 106 | P17509 | |
| EDTATFSGDDFSCVA | 1141 | Q13349 | |
| TEENEFSGCRSESSL | 776 | O43283 | |
| ALRDEASSSGCSETD | 521 | Q8NA29 | |
| QRNSTSDDDSGCALE | 21 | Q7Z3G6 | |
| ICDFTDQCGDSSDER | 51 | Q5VYJ5 | |
| LDSSCLDSSRDTDNG | 526 | Q9BWT3 | |
| DENGSVADESACATL | 1211 | Q9P2N4 | |
| FCGERSESFTEEGLD | 756 | O60308 | |
| SFSGDDLECRETASS | 101 | Q5HYN5 | |
| DTEVESEAFSCSEGS | 1106 | Q9Y2F5 | |
| FTNFVDCEESNSESE | 446 | Q96SD1 | |
| SSDEEGGAQSRDCDL | 701 | Q5SW24 | |
| GLGEEEDSSSERSSC | 386 | Q96PV7 | |
| EGFDRSTSLESSDCE | 41 | Q9NX09 | |
| DSGFALDSEERNCTD | 1056 | P35555 | |
| FSLDQTGSSCEDVDE | 2556 | P35555 | |
| FELSSDGRTCQDIDE | 186 | Q14393 | |
| DVSDIGSDNCSLADE | 626 | Q5TH69 | |
| LFEDDERSTDSSQQC | 1841 | Q5TH69 | |
| SCFSEADEEDIGSTA | 1036 | Q8N3K9 | |
| ELTGSDCSESNAEIE | 196 | Q9BYX4 | |
| DGEDSVCLSAGSDSE | 306 | Q96QS3 | |
| EFGESDLRSACDTVD | 4206 | Q14204 | |
| EDGDDTVATRSTELC | 366 | P04180 | |
| SDDSDVDVCFTDDQS | 681 | Q9H4Q3 | |
| AAACAVTDLSDDSDF | 356 | Q9NQZ2 | |
| SFSGDDLECRETASS | 101 | P0DMU7 | |
| DDSARTFTCDSELEA | 86 | Q8TEW6 | |
| SISRSEEFDQDGDCS | 41 | Q56UN5 | |
| ELIDTFEDDNCFSSG | 846 | Q03701 | |
| AGSERREEDSFDSDS | 126 | Q8N137 | |
| LGAVECFEEEDSNSR | 121 | Q96DY7 | |
| CFEEEDSNSRESLSL | 126 | Q96DY7 | |
| LCTADRDFSSGETAT | 306 | Q12923 | |
| DSGCDLSNEQRTESS | 101 | A8MW99 | |
| EERTCSDSEDIGSSE | 491 | Q9BRS2 | |
| SCDARFSDSEDEAAT | 281 | Q8N1G1 | |
| NCDLREDALDDSVSS | 1251 | Q7Z3J3 | |
| SERCDGFLDCSDESD | 1531 | Q92673 | |
| CESGFIEEVTDDSSF | 41 | Q9Y4L5 | |
| GSRVFCVEEEDSESS | 381 | Q14684 | |
| CRDDSGTDDSVDTQQ | 46 | Q96DX4 | |
| NISCVVSDGSADDFS | 1366 | Q9UPZ6 | |
| RSRSCSESDDDDSSE | 346 | P30414 | |
| GESDSDDNCTDVTAA | 211 | Q7Z494 | |
| DSGFFCEENSSDDDV | 221 | P08567 | |
| DGSTSSAEREDLCQQ | 756 | Q9NZC9 | |
| GLCRDEEDTSFESLS | 216 | Q92844 | |
| CDDSSEFKSVDEGSN | 2951 | O75592 | |
| GASSRVTCEDLESDS | 71 | Q3SY56 | |
| SGANSEESTAAEFCR | 36 | Q13586 | |
| DSLETCLSSDGGEQD | 311 | A0A1B0GV85 | |
| RASSDVSSGTSCDEE | 136 | Q9NY30 | |
| VGFISRNSTCEDVDE | 161 | Q14246 | |
| LTDGEDNTASSCIDE | 411 | Q14CN2 | |
| DSSQDSRDRGNSCDS | 561 | Q70EK8 | |
| EHSDAEVSCTDNGTF | 286 | Q86VR2 | |
| SENEEDTLCFVENSG | 456 | Q5QJE6 | |
| ENRSESDASDQSFGC | 26 | Q12870 | |
| IDSLCGSRSENESEA | 236 | O75351 | |
| ASDDEDSSEGQVQCR | 661 | Q8N5D0 | |
| DSDSDRIGDTCDNNQ | 846 | P07996 | |
| SETEDDDSHCSFQDR | 1076 | O75762 | |
| AEGVGRFESCSSDEE | 96 | O14924 | |
| EEGRCSSSDDDTDVD | 141 | Q96AQ6 | |
| EVNEEGTEAAAASSC | 321 | P50453 | |
| DEQLSSLDRDSGQCS | 361 | Q13905 | |
| ENICELSEQRGSFSD | 466 | Q9NS62 | |
| FDSSICSGEGDDSLR | 1011 | Q7Z5K2 | |
| LEDAGSSDISSDAAC | 336 | Q92576 | |
| DDSSDDGFLADDNCS | 941 | Q9GZR1 | |
| QDLDCSSSDDEGAAQ | 291 | P08240 | |
| QSETDCDVGEALDAS | 166 | Q9UBS9 | |
| FECNDSGEDCTRSST | 116 | A8MUZ8 | |
| RNCRDFDTDITDSSA | 401 | Q8IZJ1 | |
| DEFLSCDSSSDRGEG | 281 | Q9Y2K6 | |
| DTDENQGTLTFEEFC | 191 | Q4KWH8 | |
| DSGESEADLECSFAA | 991 | O43379 | |
| RACASSETESEAGDI | 1311 | Q96AY4 | |
| SETACEDRSNAESLD | 31 | Q9NWZ5 | |
| FCLADSDEESSSAGS | 941 | Q8IWB9 | |
| VVSEACDADDADNAS | 291 | Q6N021 | |
| NECEEAFNDSSSLEL | 266 | Q14590 | |
| VSTDEDVRITDCFSG | 2226 | P15822 | |
| TTAVSSNRDHEDDGC | 171 | Q8N7P7 | |
| ADAASCRDSSGEDAD | 291 | Q9H2S5 | |
| AAEDTCDVGVSSDDD | 176 | Q92539 |